These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12467504)

  • 21. Aerosol delivery during mechanical ventilation.
    Hess D
    Minerva Anestesiol; 2002 May; 68(5):321-5. PubMed ID: 12029238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design characteristics for drug nebulizers.
    Dennis JH; Hendrick DJ
    J Med Eng Technol; 1992; 16(2):63-8. PubMed ID: 1404307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New frontiers in aerosol delivery during mechanical ventilation.
    Dhand R
    Respir Care; 2004 Jun; 49(6):666-77. PubMed ID: 15165301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerosol delivery through an artificial airway.
    MacIntyre NR
    Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.
    Waldrep JC; Dhand R
    Curr Drug Deliv; 2008 Apr; 5(2):114-9. PubMed ID: 18393813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.
    Dhand R; Sohal H
    Expert Rev Med Devices; 2008 Jan; 5(1):9-18. PubMed ID: 18095891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
    Knoch M; Keller M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging aerosol drug delivery strategies: from bench to clinic.
    Rubin BK; Williams RW
    Adv Drug Deliv Rev; 2014 Aug; 75():141-8. PubMed ID: 24993613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of issues relating to nebulizer standards.
    Dennis JH
    J Aerosol Med; 1998; 11 Suppl 1():S73-9. PubMed ID: 10180736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The function and performance of aqueous aerosol devices for inhalation therapy.
    Carvalho TC; McConville JT
    J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of aerosolized drugs.
    Wolff RK; Niven RW
    J Aerosol Med; 1994; 7(1):89-106. PubMed ID: 10147060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer.
    Pedersen KM; Handlos VN; Heslet L; Kristensen HG
    J Aerosol Med; 2006; 19(2):175-83. PubMed ID: 16796542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers.
    Takanami C; Goto Y
    J Aerosol Med; 1990; 3(1):45-52. PubMed ID: 10147674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosolized iloprost customized for the critically ill.
    Harris KW; O'Riordan TG; Smaldone GC
    Respir Care; 2007 Nov; 52(11):1507-9. PubMed ID: 17971254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization.
    Beck-Broichsitter M; Oesterheld N
    Eur J Pharm Biopharm; 2017 Oct; 119():11-16. PubMed ID: 28499855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.
    Zarogoulidis P; Petridis D; Ritzoulis C; Li Q; Huang H; Ning Y; Darwiche K; Freitag L; Zarogoulidis K
    Int J Pharm; 2013 Dec; 458(1):39-47. PubMed ID: 24140545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.